This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Systemic onset juvenile idiopathic arthritis

Authoring team

Systemic-onset JIA (S-JIA) comprises around 10% of JIA (1,2)

  • it is responsible for a significant percentage of the morbidity and mortality caused by JIA
  • affects both female and males with the same frequency
  • may occur at any time during childhood
  • unlike patients with other categories of JIA, those with systemic JIA present with markedly elevated levels of inflammatory markers, fevers, and rashes (3)
    • in the initial presentation, arthritis may not be present
  • early in the disease course, systemic JIA resembles monogenic autoinflammatory syndromes such as familial Mediterranean fever

Presentation of the condition (1,2)

  • arthritis
    • normally polyarticular
    • presents within the first 3 months of onset
  • extra-articular features
    • intermittent fever for at least 2 weeks plus one of the following
      • temperature rises up to 39.5 °C once or twice in a day
      • generally accompanied by a typical, salmon pink-coloured rash
    • typical rash
      • classic salmon-coloured evanescent rash
      • there is discrete circumscribed macules that may be surrounded by a ring of pallor or develop central clearing
      • vanishes with the decline of the fever
      • found most commonly on the trunk, axilla, and inguinal areas
      • may be exacerbated by stress, or a hot bath
    • generalized lymphadenopathy
      • seen in about one-third of patients
    • hepatosplenomegaly
      • seen in about one-third of patients
    • serositis
      • includes pericarditis and pleuritis

Note:

  • fever and rash generally resolve after the emergence of polyarthritis making the diagnosis of S-JIA difficult to differentiate from regular polyarticular JIA

Reference:

  1. Barut K, Adrovic A, Şahin S, Kasapçopur Ö. Juvenile Idiopathic Arthritis. Balkan Medical Journal. 2017;34(2):90-101.
  2. Kahn P.Juvenile idiopathic arthritis - an update on pharmacotherapy. Bull NYU Hosp Jt Dis. 2011;69(3):264-76.
  3. Sandborg CI et al. Juvenile Idiopathic Arthritis. NEJM 2025;393:162-174

Related pages

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page